Literature DB >> 2411275

5-Hydroxyindoleacetic acid in cerebrospinal fluid in alcoholic patients under different clinical conditions.

S Borg, H Kvande, P Liljeberg, D Mossberg, P Valverius.   

Abstract

Levels of 5-hydroxyindoleacetic acid, 5-HIAA, the main serotoninergic metabolite in the central nervous system, were investigated in the cerebrospinal fluid, CSF, of male alcoholics and healthy controls. During intoxication, 5-HIAA correlated positively to blood ethanol concentration and levels gradually decreased by length of abstinence. In patients investigated after three months of alcohol abstinence, subnormal levels were noted. Assuming that the level of 5-HIAA in the CSF reflects central serotoninergic activity, the results support the assumption of subnormal activity in abstinent alcoholics and an activation during abuse.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2411275     DOI: 10.1016/0741-8329(85)90106-5

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  15 in total

1.  Personality profile in type I alcoholism: long duration of alcohol intake and low serotonergic activity are predictive factors of anxiety proneness.

Authors:  K Berglund; C Fahlke; U Berggren; M Eriksson; J Balldin
Journal:  J Neural Transm (Vienna)       Date:  2006-02-06       Impact factor: 3.575

Review 2.  Role of the serotonergic system in alcohol dependence: from animal models to clinics.

Authors:  Youssef Sari; Verity R Johnson; Jason M Weedman
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

3.  CSF monoamine metabolites and lethality of suicide attempts in depressed patients with alcohol dependence.

Authors:  Leo Sher; Maria A Oquendo; Michael F Grunebaum; Ainsley K Burke; Yung-yu Huang; J John Mann
Journal:  Eur Neuropsychopharmacol       Date:  2006-06-08       Impact factor: 4.600

4.  Ethanol induced antidepressant-like effect in the mouse forced swimming test: modulation by serotonergic system.

Authors:  Nishant S Jain; Uday Kannamwar; Lokesh Verma
Journal:  Psychopharmacology (Berl)       Date:  2016-11-12       Impact factor: 4.530

5.  Chronic alcoholism in the absence of Wernicke-Korsakoff syndrome and cirrhosis does not result in the loss of serotonergic neurons from the median raphe nucleus.

Authors:  K G Baker; G M Halliday; J J Kril; C G Harper
Journal:  Metab Brain Dis       Date:  1996-09       Impact factor: 3.584

6.  The effects of chronic ethanol self-administration on hippocampal 5-HT1A receptors in monkeys.

Authors:  Elizabeth J Burnett; Kathleen A Grant; April T Davenport; Scott E Hemby; David P Friedman
Journal:  Drug Alcohol Depend       Date:  2014-01-15       Impact factor: 4.492

7.  Brain-derived neurotrophic factor gene variation influences cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol concentrations in healthy volunteers.

Authors:  Erik G Jönsson; Peter Saetre; Bodil Edman-Ahlbom; Anna Sillén; Agneta Gunnar; Dimitrios Andreou; Ingrid Agartz; Göran Sedvall; Håkan Hall; Lars Terenius
Journal:  J Neural Transm (Vienna)       Date:  2008-09-10       Impact factor: 3.575

8.  Metabolomics of Neurotransmitters and Related Metabolites in Post-Mortem Tissue from the Dorsal and Ventral Striatum of Alcoholic Human Brain.

Authors:  Mohammed Abul Kashem; Selina Ahmed; Nilufa Sultana; Eakhlas U Ahmed; Russell Pickford; Caroline Rae; Omar Šerý; Iain S McGregor; Vladimir J Balcar
Journal:  Neurochem Res       Date:  2016-01-22       Impact factor: 3.996

9.  Congenital brain serotonin deficiency leads to reduced ethanol sensitivity and increased ethanol consumption in mice.

Authors:  Benjamin D Sachs; A Ayten Salahi; Marc G Caron
Journal:  Neuropharmacology       Date:  2013-09-22       Impact factor: 5.250

10.  Inverse relationship between central serotonergic neurotransmission and blood pressure in alcohol-dependent male subjects.

Authors:  J Balldin; M Andersson; U Berggren; J Engel; M Eriksson; C Fahlke
Journal:  J Neural Transm (Vienna)       Date:  2006-02-09       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.